On Thursday, San Francisco-based R&D cloud software company Benchling announced that it has acquired Belfast-based Ovewatch Research, a software company for customers working on preclinical biopharma ...

SAN FRANCISCO, Oct. 24, 2016 /PRNewswire/ -- Benchling, the next-generation life science R&D software company, announced that is has raised $7 million in new funding. This latest funding round was led ...

SAN FRANCISCO, Jan. 31, 2017 /PRNewswire/ -- Benchling, the next-generation life science R&D software company, today announced the release of its Molecular Biology 2.0 system, an unprecedented ...

(Reuters) - Benchling, which develops software tools for scientists and pharmaceutical research organizations, has laid off 74 employees, or 9% of its workforce, its spokesperson confirmed on Friday.

In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab ...

After the last two decades of consumer Internet and mobile innovation, is biotech or bioinformatics the next wave? There are a handful of San Francisco-based startups that cross the bridge between the ...

Sajith Wickramasekara started biotech R&D software company Benchling in his MIT dorm room. Now it's worth $850 million. Sajith Wickramasekara started working on an idea for a cloud-based Crispr design ...

(Reuters) -Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New ...

Life sciences-focused cloud startup Benchling has seen its business soar over the last few years due to the pandemic, and a renewed interest in biotech among investors. Now, just as it hits a ...

SAN FRANCISCO, CA — January 27, 2020 /PRNewswire/ — Benchling, the leading life sciences R&D cloud platform, today (Jan. 27) announced the launch of Benchling for Lab Automation, a new solution to ...

Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...